Rothschild Investment LLC’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$278K Sell
3,230
-69
-2% -$6.05K 0.01% 779
2026
Q1
$298K Buy
3,299
+406
+14% +$37.3K 0.02% 552
2025
Q4
$260K Sell
2,893
-487
-14% -$46.2K 0.01% 535
2025
Q3
$333K Sell
3,380
-1,859
-35% -$184K 0.02% 453
2025
Q2
$478K Sell
5,239
-294
-5% -$28.4K 0.03% 353
2025
Q1
$626K Sell
5,533
-243
-4% -$26K 0.04% 292
2024
Q4
$610K Sell
5,776
-364
-6% -$39.1K 0.04% 308
2024
Q3
$663K Sell
6,140
-1,064
-15% -$116K 0.04% 302
2024
Q2
$782K Sell
7,204
-318
-4% -$37.5K 0.05% 266
2024
Q1
$993K Sell
7,522
-122
-2% -$15.2K 0.07% 228
2023
Q4
$930K Sell
7,644
-2,497
-25% -$279K 0.08% 201
2023
Q3
$1.14M Buy
10,141
+300
+3% +$38.1K 0.1% 191
2023
Q2
$1.43M Buy
9,841
+144
+1% +$19.6K 0.12% 167
2023
Q1
$1.25M Sell
9,697
-108
-1% -$13.6K 0.11% 185
2022
Q4
$1.25M Buy
9,805
+53
+0.5% +$6.15K 0.11% 179
2022
Q3
$1.02M Sell
9,752
-165
-2% -$18.1K 0.1% 198
2022
Q2
$1.04M Buy
9,917
+2,600
+36% +$308K 0.1% 205
2022
Q1
$936K Buy
7,317
+4,242
+138% +$511K 0.07% 239
2021
Q4
$379K Buy
3,075
+273
+10% +$35.7K 0.03% 367
2021
Q3
$398K Sell
2,802
-61
-2% -$8.97K 0.03% 350
2021
Q2
$447K Buy
2,863
+105
+4% +$17K 0.04% 337
2021
Q1
$429K Buy
2,758
+185
+7% +$28.7K 0.04% 341
2020
Q4
$385K Hold
2,573
0.04% 322
2020
Q3
$340K Sell
2,573
-360
-12% -$47K 0.04% 319
2020
Q2
$340K Sell
2,933
-670
-19% -$77.2K 0.04% 298
2020
Q1
$354K Hold
3,603
0.05% 288
2019
Q4
$524K Hold
3,603
0.05% 289
2019
Q3
$480K Sell
3,603
-84,160
-96% -$10.9M 0.06% 256
2019
Q2
$10M Sell
87,763
-4,176
-5% -$489K 1.18% 17
2019
Q1
$11.4M Sell
91,939
-658
-0.7% -$74.8K 1.34% 16
2018
Q4
$9.32M Sell
92,597
-4,990
-5% -$561K 1.25% 18
2018
Q3
$12.5M Sell
97,587
-4,419
-4% -$525K 1.47% 13
2018
Q2
$11M Buy
102,006
+927
+0.9% +$101K 1.39% 14
2018
Q1
$10.7M Buy
101,079
+1,741
+2% +$202K 1.37% 14
2017
Q4
$11.6M Buy
99,338
+17,153
+21% +$1.94M 1.26% 17
2017
Q3
$9.34M Buy
82,185
+10,524
+15% +$1.21M 1.06% 27
2017
Q2
$8.93M Buy
71,661
+7,302
+11% +$866K 1.01% 24
2017
Q1
$7.63M Buy
64,359
+721
+1% +$81.7K 0.89% 29
2016
Q4
$6.38M Buy
63,638
+3,914
+7% +$420K 0.77% 34
2016
Q3
$7.54M Sell
59,724
-2,997
-5% -$370K 0.92% 25
2016
Q2
$7.33M Sell
62,721
-206
-0.3% -$23.3K 0.94% 24
2016
Q1
$6.51M Sell
62,927
-412
-0.7% -$39.9K 0.84% 28
2015
Q4
$6.31M Buy
63,339
+12,671
+25% +$1.24M 0.8% 32
2015
Q3
$4.62M Buy
50,668
+47,174
+1,350% +$4.73M 0.61% 46
2015
Q2
$371K Hold
3,494
0.04% 349
2015
Q1
$399K Hold
3,494
0.05% 332
2014
Q4
$385K Sell
3,494
-6,206
-64% -$654K 0.05% 330
2014
Q3
$947K Sell
9,700
-103
-1% -$10.1K 0.12% 195
2014
Q2
$988K Sell
9,803
-1,030
-10% -$100K 0.13% 164
2014
Q1
$995K Sell
10,833
-344
-3% -$31.7K 0.13% 158
2013
Q4
$1.01M Sell
11,177
-69,652
-86% -$6.03M 0.14% 152
2013
Q3
$6.45M Sell
80,829
-3,914
-5% -$308K 0.95% 25
2013
Q2
$6.17M Buy
+84,743
New +$6.34M 1% 25

Other funds holding ZBH

Rothschild Investment LLC's ZBH Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Zimmer Biomet (ZBH) stake by 2.1% in Q2 2026, selling an estimated $6.05K and leaving 3,230 shares worth $278K. The position accounts for 0.01% of the portfolio, ranked #779.

Rothschild Investment LLC first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.5M in Q3 2018. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Rothschild Investment LLC held 3,230 shares of Zimmer Biomet worth $278K as of Q2 2026.
  • Rothschild Investment LLC sold 69 Zimmer Biomet shares in Q2 2026, an estimated $6.05K.
  • Zimmer Biomet made up 0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #779 holding.
  • Rothschild Investment LLC first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Rothschild Investment LLC's Zimmer Biomet position peaked at $12.5M in Q3 2018.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.